Meghan M. FitzGerald is a senior executive for Cardinal Health. FitzGerald serves as President of Specialty Solutions, a specialty healthcare business with three divisions that offers services for healthcare professionals, payors, and the pharmaceutical and biotech industries.
Specialty Solutions is one of the fastest growing businesses of Cardinal Health. During FitzGerald’s tenure, Specialty Solutions has successfully launched the business in oncology and urology offering customers a set of comprehensive services designed to improve patient care and keep costs down.
Prior to joining Cardinal Health, FitzGerald was Senior Vice president of New Markets International Division and Business Development at Medco Health Solutions, Inc., where she was responsible for leading Medco's business development efforts in the United States and internationally. She previously held positions of increasing responsibility at Pfizer Global Pharmaceuticals, where she supported business strategies and operations, including implementation of ten-year lifecycle plans for various pharmaceutical products such as Celebrex. FitzGerald has also held marketing positions at Merck and Sanofi-Synthelabo.
She is a member of the Harvard Kennedy School, Women and Public Policy and Yale University Biotech Advisory boards. In 2009 and 2010 she was voted one of Irish Americans most influential women in business.
Fitzgerald obtained a Doctor of Public Health (DrPH) degree at New York Medical College, focusing on health policy. She earned a master’s degree in public health from Columbia University and a bachelor's degree in nursing from Fairfield University. FitzGerald is adjunct faculty teaching “The Business of Healthcare” at Columbia University in New York.
Recognized as a forward-thinking leader with a clear vision for the business, FitzGerald is an expert speaker on topics such as Specialty Healthcare Market; European Healthcare Policy, Healthcare Reform; the Ever-Changing Healthcare Landscape; and Women and Executive Leadership.